💊 🩺 Get the April issue of #AustralianPrescriber! The latest articles highlight the development of several effective RSV immunisations, new treatments for patients with migraines, noninvasive prenatal testing and the effective use of vancomycin. Tap the link to learn more:

💊Laura Beaton is your host for the latest episode of the Australian Prescriber podcast, and she talks to Emma Mason, a lecturer in sexual and reproductive health at the University of Sydney. “There's so many choices for contraception available in Australia, which is really great

The June Issue of Australian Prescriber features summaries of 3 new medicines or new indications: spesolimab for generalised pustular psoriasis, talazoparib for advanced prostate or breast cancer in people with HRR gene mutations, and a new indication for semaglutide (Wegovy) for

What are safe and effective treatments options for #opioiddependence? Buprenorphine and methadone are both highly effective. Recently, long-acting injectable buprenorphine has emerged as a treatment option, offering flexible weekly or monthly dosing. Stay informed! Read this

The requirement for dual labelling of several medicines has ended and they will now transition to sole labelling with their new approved name. For example, ‘hydroxycarbamide (hydroxyurea)’ will transition to ‘hydroxycarbamide’. This is part of a process that started in 2016 that

👋 What’s new in #psoriasis treatment? 🎧Find out in the latest Australian Prescriber podcast episode➡️ Jo Cheah chats with dermatologist Jonathan Chan about updates in topical and systemic therapies, when to refer, and managing comorbidities.

Patterned hair loss is a common condition that affects both men and women (also known as androgenetic alopecia). So, how can it present, what are the potential causes, and effective pharmacological #treatments? Tap the link to #stayinformed:. #HairLoss

There are many new and effective oral and injectable medicines that can improve symptoms and quality of life for people with psoriasis that are not adequately controlled with topical therapies. To find out what's available and how to access them read this article:

💊 What’s changed in #vancomycin monitoring? Amy Legg and Tony Lai join Dhineli Perera to discuss the evolution of vancomycin therapeutic drug monitoring, including trough concentrations, and demystify AUC monitoring. They highlight priority patient groups and offer insights into

👏Congratulations to Dr Michael Steiner, Australian Prescriber’s stakeholder network representative for the Royal Australian and New Zealand College of Ophthalmologists, who has been recognised in the 2025 King’s Birthday Honours! .🏆Dr Steiner was awarded Member of the Order of

Did you know pharmacogenomic tests provide information on gene variants that may influence drug exposure or response? They can be used to help tailor drug therapy to a patient, for example, by identifying whether they are at higher risk of a serious adverse drug reaction or

There are many contraceptive options in Australia. This article provides an update on both long- and short-acting contraceptive methods. It discusses factors influencing choice of contraception, including key considerations for different population groups, such as people who are

The June Issue of #AustralianPrescriber is out👉 The new issue features an update on long- and short-acting contraceptive methods, #pharmacogenomics to personalise drug therapy, the latest management approaches for #psoriasis, medicines for treating

How does noninvasive prenatal testing (NIPT) differ from other screening options like serum screening and ultrasound? Genetic counsellor Alice Poulton joins Justin Coleman to explain how NIPT is used to screen for conditions such as Down syndrome, how to interpret results, and

RT @TGLGuidelines: ✨ Hear from our Expert Group Members ✨ . Dr. Eliza Cole is a dedicated GP from Western Australia and an invaluable memb….

📢What’s new in #RSV prevention and management? In this latest episode, David Liew chats with #paediatric infectious diseases physician Linny Phuong about updated prevention and management strategies for RSV, including when to test, who’s most at risk, and what immunisation

Osilodrostat is a new treatment for adults with endogenous Cushing syndrome. More patients achieved normal cortisol concentrations with osilodrostat compared with placebo in the key clinical trial. Regular cortisol monitoring is essential to determine an effective dose and manage

Nelarabine provides a new treatment option for T-cell acute lymphoblastic leukaemia or T-cell lymphoblastic lymphoma that has not responded to or has relapsed following treatment. Read more: #nelarabine #Tcell_leukaemia #NewDrug

Lenacapavir is a novel injectable antiretroviral treatment with a 6-month dosing frequency. It targets multiple stages of the HIV life cycle, providing a new therapeutic option for patients with HIV-1 and significant drug resistance. learn more: #NewDrug

🎙️ New #podcast #miniseries! So, what has changed in the latest version of Therapeutic Guidelines: Antibiotic? Dhineli Perera chats with Allen Cheng, director of Infectious Diseases at Monash Health and member of the Antibiotic Expert Group. Topics include: . ✅ A new tiered

Unlike most liquid medicines, clonazepam oral liquid should be ordered and measured in DROPS💧 , not millilitres. Standardising the way this medicine is ordered and measured can reduce the risk of errors like the one described in this article 👉